A detailed history of La Salle St. Investment Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, La Salle St. Investment Advisors, LLC holds 3,260 shares of AZN stock, worth $206,129. This represents 0.1% of its overall portfolio holdings.

Number of Shares
3,260
Previous 3,224 1.12%
Holding current value
$206,129
Previous $251,000 1.2%
% of portfolio
0.1%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $2,760 - $3,154
36 Added 1.12%
3,260 $254,000
Q2 2024

Aug 12, 2024

BUY
$66.81 - $80.83 $215,395 - $260,595
3,224 New
3,224 $251,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $196B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track La Salle St. Investment Advisors, LLC Portfolio

Follow La Salle St. Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of La Salle St. Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on La Salle St. Investment Advisors, LLC with notifications on news.